Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
发明人:
Florian Holsboer
申请号：
US16541622
公开号：
US20190365708A1
申请日:
2019.08.15
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to a vasopressin receptor 1B (V1B) antagonist for use in the treatment of depressive symptoms and/or anxiety symptoms in patients showing an elevated arginine vasopressin (AVP) level and/or an elevated copeptin level. The present invention further relates to a method for predicting the treatment response to a V1B antagonist in patients with depressive symptoms and/or anxiety symptoms.
